ASP Isotopes to list on Johannesburg Stock Exchange, retains Nasdaq listing.

ASP Isotopes Inc., an advanced materials company, has been approved for a secondary listing on the Johannesburg Stock Exchange (JSE). The Company's common stock will be listed on the JSE's Main Board under the abbreviated name "ASPI" and share code "ISO", with trading expected to commence on August 27, 2025. The primary listing will remain on the Nasdaq Capital Market, and the Company's issued share capital will not be affected by the dual listing. This move is not related to any current capital raising effort.

ASP Isotopes Inc. (NASDAQ: ASPI) has received approval for a secondary listing on the Johannesburg Stock Exchange (JSE), with trading expected to commence on August 27, 2025. The company's common stock will be listed on the JSE's Main Board under the abbreviated name "ASPI" and share code "ISO". The primary listing on the Nasdaq Capital Market will remain unaffected, and the company's issued share capital will not be altered by this dual listing [1].

This strategic move is part of ASP Isotopes' broader expansion plans, which include the acquisition of Renergen Limited, a South African company, through a scheme of arrangement. The acquisition, supported by 99.8% of Renergen shareholders, aims to create a global leader in critical materials. The combined entity targets over $300 million in EBITDA by 2030, driven by isotopes, helium, and LNG sales [1].

The secondary listing on the JSE is not conditional on the Renergen acquisition but is expected to enhance the company's South African presence. ASP Isotopes currently has 97% of its employees and all operating assets in South Africa, making this a natural market extension [1].

The company's Chairman and CEO, Paul Mann, stated, "While our capital base has been created in the USA and Europe, the heartbeat of our company is clearly in South Africa, with 97% of our employees and all our operating assets currently being located in South Africa. We have to thank the South African people for helping us achieve all we have done over the last four years and therefore we owe it to the South African people to make our securities available on the JSE." [1]

The dual listing and acquisition aim to create a vertically and horizontally integrated supply chain, focusing on electronic gases, fluorinated products, and isotopically enriched gases, which are considered strategically vital materials by Western governments [1].

The transaction is expected to be highly accretive to ASPI's revenue, EBITDA, earnings per share, and cash flow per share during 2026. The goal of the combined group is to generate over $300 million in EBITDA in 2030, driven by isotopes, helium, and LNG sales into the South African energy market [1].

References:

[1] https://www.stocktitan.net/news/ASPI/asp-isotopes-inc-announces-expected-commencement-of-dual-listing-on-5x119le2ucnf.html